id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-0061-0004,FDA,FDA-1999-D-0061,FDA,Other,ELET-Electronic Letter,2003-01-02T05:00:00Z,2003,1,,,2008-04-25T00:14:30Z,,0,0,09000064804a6775
FDA-1999-D-0061-0002,FDA,FDA-1999-D-0061,Guidance,Supporting & Related Material,GDL-Guidance,2000-02-03T05:00:00Z,2000,2,,,2008-04-25T00:14:30Z,,0,0,09000064804a6773
FDA-1999-D-0061-0003,FDA,FDA-1999-D-0061,HFZ-220,Other,NAD-Notice of Availability of Data,2000-02-03T05:00:00Z,2000,2,,,2024-11-07T21:52:50Z,,1,0,09000064804a6774
FDA-1999-D-0061-0001,FDA,FDA-1999-D-0061,Draft Guidance for Industry on Testing Orthopedic Implants with Metallic Plasma Sprayed Coatings to Support Reconsideration of Postmarket Surveillance Requirements; Availability,Notice,Notice of Data Availability,1999-02-23T00:00:00Z,1999,2,1999-02-23T00:00:00Z,1999-05-25T03:59:59Z,2025-05-15T09:00:10Z,99-4213,0,0,09000064804a6768